ERVA NEWS – Know more, Feel better
  • Business & Industry
    • Market Analysis & Trends
    • Investment opportunities
    • Company Profiles & Statistics
    • Mergers & Acquisitions
    • Marketing Strategies & Supply Chain Insights
  • Health & Wellness
    • Medical Research & CBD Benefits
    • Treatment Options & Dosage Guidelines
    • Mental Health Applications & Patient Testimonials
    • Wellness Routines, Athletic Recovery & Sleep Improvement
  • Science & Technology
    • Cannabinoid & Terpene Research
    • Cultivation Techniques & Genetic Studies
    • Extraction Methods & Bioavailability
    • Lab Testing & Cultivation Science
  • Legal & Policy
    • State, Federal & International Laws
    • Regulatory Changes & Compliance Guides
    • Licensing, Banking Regulations & Taxation
    • Social Equity, Local Ordinances & Import/Export Rules
  • Lifestyle & Culture
    • Consumption Guides & Product Reviews
    • Recipes & Storage Tips
    • Event Coverage & Travel Guides
    • Celebrity News, Community Stories, Art & Music
  • Shop

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Florida Billionaire Donates $20M to Candidates that Oppose Cannabis Legalization Effort

December 8, 2024

New York Officials Release Multi-Year Cannabis Industry Report

December 8, 2024

Vice Presidential Nominee Tim Walz Has A Rating from NORML for Cannabis Policy

December 7, 2024
Facebook Twitter
Facebook Twitter
ERVA NEWS – Know more, Feel better
Monday, June 2
  • Business & Industry
    • Market Analysis & Trends
    • Investment opportunities
    • Company Profiles & Statistics
    • Mergers & Acquisitions
    • Marketing Strategies & Supply Chain Insights
  • Health & Wellness
    • Medical Research & CBD Benefits
    • Treatment Options & Dosage Guidelines
    • Mental Health Applications & Patient Testimonials
    • Wellness Routines, Athletic Recovery & Sleep Improvement
  • Science & Technology
    • Cannabinoid & Terpene Research
    • Cultivation Techniques & Genetic Studies
    • Extraction Methods & Bioavailability
    • Lab Testing & Cultivation Science
  • Legal & Policy
    • State, Federal & International Laws
    • Regulatory Changes & Compliance Guides
    • Licensing, Banking Regulations & Taxation
    • Social Equity, Local Ordinances & Import/Export Rules
  • Lifestyle & Culture
    • Consumption Guides & Product Reviews
    • Recipes & Storage Tips
    • Event Coverage & Travel Guides
    • Celebrity News, Community Stories, Art & Music
  • Shop
ERVA NEWS – Know more, Feel better
Home»Legal & Policy»DEA Letter to Congress Asserts “Final Authority” on Cannabis Scheduling
Legal & Policy

DEA Letter to Congress Asserts “Final Authority” on Cannabis Scheduling

January 4, 2024Updated:January 24, 2025No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

In a latest letter to congress that was Up to date by Punchbowl News, a DEA consultant asserted that the Drug Enforcement Administration has “closing authority” on any choice concerning the standing of hashish underneath the Managed Substances Act. Amid quite a few energetic efforts to vary how the federal authorities treats hashish which have been taking part in out in congress, courts, and the chief department, this assertion by the DEA highlights the complexity of the state of affairs.

The DEA is presently reviewing the federal classification of marijuana as a Schedule 1 drug, following a advice from the Division of Well being and Human Providers (HHS) to reclassify hashish to a much less restrictive Schedule III, indicating a shift in perspective on its medical worth and potential for abuse. In the meantime, public help of hashish legalization is at an all-time-high: a latest Gallup ballot revealed that seven in ten Individuals help a change in coverage.

Whereas the HHS has made its stance clear, the DEA holds the ultimate authority to reschedule or deschedule medication underneath the Managed Substances Act. Regardless of the continuing evaluate initiated underneath President Biden’s directive, the DEA has not supplied a timeline or clear indication of its place, sustaining a secretive and procedural stance.

This lack of transparency and the DEA’s energy to make a closing choice have prompted frustration amongst lawmakers, advocates, and the general public. Critics argue that the DEA ought to align with the evolving public opinion and Congressional requires legalization. In response, Rep. Earl Blumenauer, co-chair of the Congressional Hashish Caucus, and different lawmakers have urged the DEA to acknowledge the deserves of legalization and contemplate a extra progressive method throughout their evaluate.

The secretive nature of the HHS’s rationale for recommending the rescheduling of hashish, with solely closely redacted paperwork obtainable to the general public, additional complicates the difficulty. Though the Congressional Analysis Service means that the DEA would possibly observe the HHS’s advice primarily based on historic precedent, the company’s present opaque method leaves the end result unsure.

As the controversy continues, stakeholders eagerly await the DEA’s choice, which may have vital implications for federal hashish coverage and broader efforts in direction of reform.

Get day by day hashish enterprise information updates. Subscribe

Source link

Asserts Authority cannabis cannabis law Compliance Congress DEA Final legal updates Letter marijuana legislation Regulations Scheduling
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous Article10 Best Edibles and THC Gummies in 2023
Next Article Oklahoma Introduces ‘Secret Shoppers’ to Help Regulate Medical Cannabis Industry

Related Posts

Florida Billionaire Donates $20M to Candidates that Oppose Cannabis Legalization Effort

December 8, 2024

New York Officials Release Multi-Year Cannabis Industry Report

December 8, 2024

Vice Presidential Nominee Tim Walz Has A Rating from NORML for Cannabis Policy

December 7, 2024

Delaware Receives 1,260 Adult-Use Cannabis Applications

December 7, 2024

Comments are closed.

Our Picks

Florida Billionaire Donates $20M to Candidates that Oppose Cannabis Legalization Effort

December 8, 2024

New York Officials Release Multi-Year Cannabis Industry Report

December 8, 2024

Vice Presidential Nominee Tim Walz Has A Rating from NORML for Cannabis Policy

December 7, 2024

Delaware Receives 1,260 Adult-Use Cannabis Applications

December 7, 2024
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Legal & Policy

Florida Billionaire Donates $20M to Candidates that Oppose Cannabis Legalization Effort

December 8, 20240

In an August 2 op-ed, Ken Griffin, the billionaire investor and CEO of Florida-based Citadel…

New York Officials Release Multi-Year Cannabis Industry Report

December 8, 2024

Vice Presidential Nominee Tim Walz Has A Rating from NORML for Cannabis Policy

December 7, 2024

Delaware Receives 1,260 Adult-Use Cannabis Applications

December 7, 2024
logo

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Social mendia

Facebook-f Twitter

Categories

  • Business & Industry
  • Health & Wellness
  • Science & Technology
  • Legal & Policy
  • Lifestyle & Culture
  • Business & Industry
  • Health & Wellness
  • Science & Technology
  • Legal & Policy
  • Lifestyle & Culture

Our Picks

Florida Billionaire Donates $20M to Candidates that Oppose Cannabis Legalization Effort

December 8, 2024

New York Officials Release Multi-Year Cannabis Industry Report

December 8, 2024

Vice Presidential Nominee Tim Walz Has A Rating from NORML for Cannabis Policy

December 7, 2024
© 2024 ervanews.com. All rights reserved.